WuXi PharmaTech Announces Fourth Quarter and Full Year 20...(se these forward-lookingstatements wheth...)

WUXI PHARMATECH (CAYMAN) INC.

UNAUDITED CONSOLIDATED BALANCE SHEETS

(in thousands of US Dollars, except ordinary share,

ADS and par value data)

December 31, December 31,

2007 2006

Assets:

Current assets:

Cash and cash equivalents 213,585 9,683

Restricted cash 5,526 2,067

Accounts receivables, net 18,199 12,589

Inventories 13,352 9,617

Prepaid expenses and other current assets 11,215 2,696

Total current assets 261,877 36,652

Non-current assets:

Property, plant and equipment, net 73,635 42,776

Intangible assets, net 921 628

Land use rights, net 5,160 4,643

Other non-current assets 2,182 992

Total non-current assets 81,898 49,039

Total assets 343,775 85,691

Liabilities, mezzanine equity and

shareholders' equity (deficit):

Current liabilities:

Short-term bank borrowings, current -- 9,604

Accounts payable 7,217 9,259

Accrued expenses 12,279 5,012

Deferred revenue
'/>"/>